Tg(CAG-OVAL)916Jen
Transgene Detail
|
|
| Symbol: |
Tg(CAG-OVAL)916Jen |
| Name: |
transgene insertion 916, Marc K Jenkins |
| MGI ID: |
MGI:3050829 |
| Synonyms: |
Actin-mOVA, actin-OVA, Act-mOVA, ActmOVA, actOVA, Tg(ACTB-OVA)916Jen, Tg(CAG-OVA)916Jen |
| Transgene: |
Tg(CAG-OVAL)916Jen Location: unknown
|
| Alliance: |
Tg(CAG-OVAL)916Jen page
|
|
|
|
| Transgene Type: |
|
Transgenic (Inserted expressed sequence) |
| Mutation: |
|
Insertion
|
| |
|
Tg(CAG-OVAL)916Jen expresses
1 gene
Transgene expresses:
| Organism |
Expressed Gene |
Note |
| chicken |
OVAL (396058) |
|
|
| |
|
Tg(CAG-OVAL)916Jen expression driven by
1 gene
Transgene expression driven by:
| Organism |
Driver Gene |
Note |
| chicken |
CAG |
|
|
| |
|
Mutation details: The transgene consists of a full-length chicken ovalbumin cDNA preceded by the 5' leader sequence of the mouse H2-Kb gene and followed by the DNA sequence encoding the short extracellular spacer and transmembrane domain of the mouse H2-Db gene joined to the rabbit beta-globin polyadenylation signal; its expression is driven by the chicken beta-actin promoter under control of the CMV immediate early enhancer. Ovalbumin expression was detected immunohistochemically on the surfaces of cells of all organs and shown to function in skin-graft experiments as a minor histocompatibility antigen that triggered graft rejection by a mechanism involving both CD4 and CD8 T lymphocytes.
(J:91742)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
| Original: |
J:91742 Ehst BD, et al., Development of a novel transgenic mouse for the study of interactions between CD4 and CD8 T cells during graft rejection. Am J Transplant. 2003 Nov;3(11):1355-62 |
| All: |
73 reference(s) |
|